Registered entities
EnLiven Therapeutics, Inc.
Reg. No. 20201617684United States
Enliven Therapeutics, Inc.
Reg. No. 1672619United States
Enliven
Reg. No. 40203447620Latvia
Social engagement
Social engagement: 6.2K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
17 investors on record; lead investors include Orbimed, 5AM Ventures, Cormorant Asset Management, Surveyor Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 47% |
| Private equity | 3 | 18% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 5 | 29% |
Recent activity
10 Jun 2026
Event
EHA2026
9 Jun 2026
Event
European Hematology Association (EHA) Congress
4 Jun 2026
Event
Jefferies Global Healthcare Conference